Pharma presented results showing statistically significant improvements in clinical outcomes as compared to placebo for time ...

Acoramidis’s hazard ratio of .41 for time to ACM or first CVH versus placebo in the ATTRibute-CM study subgroup of ATTRv-CM patients achieved ...

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.

Background Cardiac cachexia is a condition characterised by unintentional weight loss and muscle wasting in patients with ...

"As a cancer patient, having options to manage the side effects of life saving drugs is very important. I believe the published results of crofelemer for the prophylaxis of CTD are very exciting and ...

Two videoconferences will be held tomorrow, March 27, 2025in French at 05:30pm CET and in English at 07:30pm CET (02:30pm ET) ...

In subgroup analysis by intervention modality, sports and PA programme (SMD=0.21, 95% CI 0.12 to 0.31, p<0.05) and curricular PA (SMD=0.39, 95% CI 0.08 to 0.69, p<0.05) improved overall EFs ...

Mathematics and computing is the study and analysis of abstract concepts ... Our approach improved subgroup estimates, guiding targeted public health strategies and addressing biases in ...

Results The majority of participants in the review were from sporting populations. Meta-analysis revealed that tendon abnormalities on US are associated with future symptoms of both patellar and ...